10 completed, 1 recruiting, 1 terminated, 1 unknown. 14 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 14 | Completed 10, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1 |
Follow Testosterone Propionate: new trials by email Literature Review of Testosterone Propionate trials Research Report on Testosterone Propionate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance Biopsy of Prostate, Biospecimen Collection, Magnetic Resonance Imaging - Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8 | Phase 4 | Recruiting | Roswell Park Cancer Institute | 600 | 2025-01-15 | 2026-05-14 |
| Patient Satisfaction After Switching to Oral Testosterone Undecanoate Jatenzo - Testosterone Deficiency | Phase 4 | Completed | University of Miami | 41 | 2021-06-18 | 2023-12-14 |
| Vogelxo(R) ABPM Study in Hypogandal Men Vogelxo - Hypogonadism, Male | Phase 4 | Completed | Upsher-Smith Laboratories | 122 | 2020-08-28 | 2024-10-18 |
| A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism Aveed Injectable Product, Fortesta, Testim - Hypogonadism, Hypogonadism, Male | Phase 4 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 673 | 2020-06-30 | 2025-03-14 |
| Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations Testosterone Undecanoate, Sesame Oil - Caloric Restriction, Exercise | Phase 4 | Completed | Pennington Biomedical Research Center | 34 | 2019-09-23 | 2022-10-07 |
| Xiaflex® Plus Testosterone Treatment Pilot Study Protocol Xiaflex®, Aveed - Peyronie's Disease (PD) | Phase 4 | Completed | Men's Health Boston | 20 | 2019-01-14 | 2020-12-31 |
| Hormones and Decision Making testosterone propionate, 0.5% cholorbutanol, saline - Dyssocial Behavior | Phase 4 | Completed | University of Texas at Austin | 30 | 2015-03-01 | 2021-04-29 |
| The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel Topical Testosterone Solution - Hypogonadism | Phase 4 | Completed | Eli Lilly and Company | 78 | 2013-07-01 | 2014-10-27 |
| Testosterone and Pain Sensitivity Testosterone Gel, Placebo Gel - Low Testosterone, Hypogonadism | Phase 4 | Withdrawn | Johns Hopkins University | 2012-08-01 | 2015-03-31 | |
| NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH) Testosterone Undeconate (Nebido, BAY86-5037), Placebo - Hypogonadism | Phase 4 | Terminated | Bayer | 4 | 2010-09-01 | 2014-11-05 |
| Metabolic Syndrome Criteria and the Effect of Testosterone Treatment in Young Men With Hypogonadism Testosteron - Hypogonadism | Phase 4 | Completed | Gulhane School of Medicine | 312 | 2009-08-01 | 2010-07-12 |
| The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups Testosteron 250mg injection, Testosterone 50mg transdermal application - Secondary Hypogonadism | Phase 4 | Completed | Gulhane School of Medicine | 140 | 2008-09-01 | 2011-10-18 |
| Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy Testosterone 250mg injection, Testosteron 50 mg transdermal gel - Hypogonadotrophic Hypogonadism | Phase 4 | Completed | Gulhane School of Medicine | 130 | 2008-08-01 | 2014-06-24 |
| Odense Androgen Study - The Effect of Testim and Training in Hypogonadal Men Testim, Strength training, placebo - Hypogonadism, Metabolic Syndrome | Phase 4 | Unknown | Odense University Hospital | 60 | 2008-04-01 | 2009-09-21 |
Hypogonadism (9) · Eunuchism (2) · Metabolic Syndrome (2) · Motor Activity (2) · Antisocial Personality Disorder (1) · Inflammation (1) · Insulin Resistance (1) · Pain (1) · Penile Induration (1) · Prostatic Neoplasms (1)
Gulhane School of Medicine (3) · Bayer (1) · Eli Lilly and Company (1) · Endo USA Inc., a Keenova Therapeutics Company (1) · Johns Hopkins University (1) · Men's Health Boston (1) · Odense University Hospital (1) · Pennington Biomedical Research Center (1) · Roswell Park Cancer Institute (1) · University of Miami (1) · University of Texas at Austin (1) · Upsher-Smith Laboratories (1)
United States (9) · Turkey (Türkiye) (3) · Denmark (1) · Germany (1)
Abraham Morgentaler, MD (1) · Ahmed Aly (1) · David Hernandez (1) · Jennifer C Rood, PhD (1) · Marianne Andersen, Md, phd (1) · Ranjith Ramasamy, MD (1) · Robert A Josephs, PhD (1)
PMID 17983892, PMID 23730808, PMID 24089589, PMID 29656500, PMID 32853647, PMID 34278044, PMID 36796647, PMID 36949577, PMID 40279652
2009 (1)